NVDA vs PAYS

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

PAYS exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is currently trading at a severe premium to its deterministic value (Graham Number: $1.60, Intrinsic Value: $0.91). While revenue growth is explosive at 45.8%, this has not yet translated into bottom-line earnings growth, which remains slightly negative (-3.60%). The stock has experienced a parabolic 1-year run (+179.4%), leading to a high trailing P/E of 44.92, though the Forward P/E of 15.07 suggests significant expected earnings acceleration. Overall, the company is fundamentally healthy but valuationally overextended.